501
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Characterization of ascites in cardiac cirrhosis: the value of ascitic fluid protein to screen for concurrent cardiac cirrhosis

, , , , , & show all
Pages 898-903 | Received 14 Mar 2017, Accepted 22 Apr 2017, Published online: 09 May 2017

References

  • Vollmar B, Menger MD. The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair. Physiol Rev. 2009;89:1269–1339.
  • Kavoliuniene A, Vaitiekiene A, Cesnaite G. Congestive hepatopathy and hypoxic hepatitis in heart failure: a cardiologist's point of view. Int J Cardiol. 2013;166:554–558.
  • Giallourakis CC, Rosenberg PM, Friedman LS. The liver in heart failure. Clin Liver Dis. 2002;6:947–967.
  • Naschitz JE, Slobodin G, Lewis RJ, et al. Heart diseases affecting the liver and liver diseases affecting the heart. Am Heart J. 2000;140:111–120.
  • Fouad YM, Yehia R. Hepato-cardiac disorders. World J Hepatol. 2014;6:41–54.
  • Fuhrmann V, Kneidinger N, Herkner H, et al. Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients. Intensive Care Med. 2009;35:1397–1405.
  • Myers RP, Cerini R, Sayegh R, et al. Cardiac hepatopathy: clinical, hemodynamic, and histologic characteristics and correlations. Hepatology. 2003;37:393–400.
  • Runyon BA, Montano AA, Akriviadis EA, et al. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann Intern Med. 1992;117:215–220.
  • Runyon BA. Cardiac ascites: a characterization. J Clin Gastroenterol. 1988;10:410–412.
  • Christou L, Economou M, Economou G, et al. Characteristics of ascitic fluid in cardiac ascites. Scand J Gastroenterol. 2007;42:1102–1105.
  • Akriviadis EA, Kapnias D, Hadjigavriel M, et al. Serum/ascites albumin gradient: its value as a rational approach to the differential diagnosis of ascites. Scand J Gastroenterol. 1996;31:814–817.
  • Strikas RA. Advisory committee on immunization practices recommended immunization schedules for persons aged 0 through 18 years–United States, 2015. MMWR. 2015;64:93–94.
  • Garcia ‐Tsao G, Sanyal AJ, et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46:922–938.
  • de Franchis R, Faculty BVI. Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63:743–752.
  • Bruix J, Sherman M. Aasld Practice Guideline. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020–1022.
  • Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non‐alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55:2005–2023.
  • Gupta S, Barter S, Phillips GW, et al. Comparison of ultrasonography, computed tomography and 99mTc liver scan in diagnosis of Budd-Chiari syndrome. Gut. 1987;28:242–247.
  • Møller S, Bernardi M. Interactions of the heart and the liver. Eur Heart J. 2013;34:2804–2811.
  • Kim MS, Kato TS, Farr M, et al. Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction. J Am Coll Cardiol. 2013;61:2253–2261.
  • McAvoy NC, Semple S, Richards JMJ, et al. Differential visceral blood flow in the hyperdynamic circulation of patients with liver cirrhosis. Aliment Pharmacol Ther. 2016;45:947–954.
  • Villanueva C, Albillos A, Genescà J, et al. Development of hyperdynamic circulation and response to β-blockers in compensated cirrhosis with portal hypertension. Hepatology. 2016;63:197–206.
  • Siniscalchi A, Aurini L, Spedicato S, et al. Hyperdynamic circulation in cirrhosis: predictive factors and outcome following liver transplantation. Minerva Anestesiol. 2013;79:15–23.
  • Valeriano V, Funaro S, Lionetti R, et al. Modification of cardiac function in cirrhotic patients with and without ascites. Am J Gastroenterol. 2000; 95:3200–3205.
  • Ortiz-Olvera NX, Castellanos-Pallares G, Gómez-Jiménez LM, et al. Anatomical cardiac alterations in liver cirrhosis: an autopsy study. Ann Hepatol. 2011; 10:321–326.
  • Beg M, Husain S, Ahmad N, et al. Serum/ascites albumin gradient in differential diagnosis of ascites. J Indian Acad Clin Med. 2001;2:51–54.
  • Gupta R, Misra SP, Dwivedi M, et al. Diagnosing ascites: value of ascitic fluid total protein, albumin, cholesterol, their ratios, serum-ascites albumin and cholesterol gradient. J Gastroenterol Hepatol. 1995;10:295–299.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.